● Recruiting

Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.

Condition: Recurrent Acute Pancreatitis · Sponsor: University of Alabama at Birmingham

PhasePhase 2

Planned participants60

Who can joinAll sexes, 18 Years to 85 Years

Healthy volunteersNo

About this study

This clinical will evaluate the safety, tolerability and early efficacy of pirenidone in patients with recurrent acute pancreatitis.

This description comes directly from the study's public registry record.

Talk to the study team

kondal Kyanam, M.B.B.S. · (205) 975-3593 · kbaig@uabmc.edu

Santhi Swaroop Vege, M.D.

Always discuss trial participation with your own doctor first.

Locations (2)

UAB	Birmingham, Alabama, United States	Recruiting
Mayo Clinic	Rochester, Minnesota, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06253117